Courses

New Evidence to Support Optimal, Early Nutrition Intervention to Improve Patient Outcomes

Program Date: 29 March 2020

Publication Date: 10 June 2020

Continuing Education Credits: Nurse Contact 1.0 CE; Dietitian 1.0 CPEU

Course Description

In this course, Nicolaas Deutz, MD, PhD, and Philipp Schuetz, MD, MPH, will summarize new evidence supporting the benefits of early nutrition intervention in at-risk patient populations; illustrate the health, economic, and cost benefits of nutrition intervention; and evaluate the implementation of new evidence and science into clinical practice. Originally presented at the 2020 virtual ASPEN Conference on 30 March 2020.

Course Objectives:
  • Summarize new evidence supporting the benefits of early nutrition intervention in at-risk patient populations.
  • Illustrate the health, economic and cost benefits of nutrition intervention.
  • Evaluate the implementation of new evidence and science into clinical practice.

Performance Indicators: 4.1.2, 4.2.6, 8.2.3

Activity Code: 180336

Course Instructor Bio(s)

Nicolaas Deutz, MD, PhD

Professor, Ponder Endowed Chair
Editor-in-Chief, Clinical Nutrition
Director, Center for Translational Research in Aging & Longevity
Texas A&M University
College Station, TX, USA

Dr Nicolaas Deutz, MD, PhD, currently serves as Director for the Center for Translational Research in Aging and Longevity (CTRAL). For more than 30 years, his research background and expertise have focused on nutrition, metabolism, and physiology studies involving stable isotope methodologies in humans and animals. Dr Deutz has extensive experience with isotopic calculations, validation, and data interpretation. The stable isotope approaches are used in several studies to unravel the metabolic changes in patients with chronic diseases (i.e., chronic obstructive pulmonary disease, cancer, cystic fibrosis, chronic heart failure, obstructive sleep apnea, mild cognitive impairment and dementia, autism spectrum disorder). This research led to new insights into protein and amino acid kinetics in subjects with chronic disease. It resulted in specific recommendations for nutritional supplements to reduce muscle wasting. Recently, he started studying the anabolic effects of specialized nutritional supplements in different chronic diseases and models of disease. Using translational approaches is a logical extension of the body of his research in the field of protein and amino acids metabolism. Dr Deutz obtained his MD and PhD at the University of Amsterdam, Netherlands

Philipp Schuetz, MD, MPH

Internal Medicine & Emergency Medicine  
Medical University Department  
Kantonsspital Aarau, Tellstrasse  
Aarau, Switzerland

Philipp Schuetz was born in Switzerland and is a board-certified internist and endocrinologist. He obtained a Master of Public Health (MPH) at the Harvard School of Public Health Boston while doing clinical research at the Beth Israel Deaconess Medical Center (BIDMC). He currently has a professorship from the Swiss National Foundation and works clinically at the Medical University department at the Kantonsspital Aarau in the emergency department and the Endocrine unit; and is in charge of clinical studies focusing on clinical nutrition (EFFORT), as well as on improved triage and management of patients throughout their hospital stay with the use of novel biomarkers.

Category

Abbott Nutrition’s Provider Statement for Nursing CEs:

Abbott Nutrition Health Institute is an approved provider of continuing nursing education by the California Board of Registered Nursing Provider #CEP 11213.

Abbott Nutrition’s Statement for Dietitian CPEUs:

This educational activity has been prior-approved by the Commission on Dietetic Registration (CDR). CDR credentialed practitioners will receive the specified continuing professional education units (CPEUs) for completion of this program/material.